Running for Rare: Why We’re Taking on the Cambridge Half for CamRARE

Running for Rare: Why We’re Taking on the Cambridge Half for CamRARE

Rare diseases may be individually uncommon, but together they affect millions—yet they often remain overlooked. As students at the University of Cambridge, we’ve been inspired by the incredible work of CamRARE in uniting patients, researchers, and advocates to drive change in the rare disease space. That’s why we’re lacing up our running shoes for the Cambridge Half Marathon—to raise awareness, funds, and support for a cause close to our hearts.

In this blog, we (Athena, Ryan, and Zachary) share our motivations, our connection to rare diseases, and our hopes for a future where no patient is left behind. Read on to find out why we’re running and how you can support us!

Katie sat with glasses and mid length blonde hair in a black shirt

Introductions

Athena Ham, 5th Year Medicine, University of Cambridge

Ryan Lin, 4th Year Engineering, University of Cambridge

  • I am an engineering student with a specialisation in information and computer engineering.
  • Fun fact: In 2024, I was the top buyer of filtered full cream milk from Sainsburys Sidney Street.

Zachary Yong, 2nd Year Law, University of Cambridge

  • I am a law student with an interest in genetics and public law. In my free time, I like to cook, play the piano, read and exercise.
  • Fun fact: I enjoy listening to Handel’s Oratorios.

Why Rare Disease?

An estimated 1 in 17 people will be affected by a rare disease during their lifetime. Although each disease is individually rare, together rare diseases affect an estimated 3.5 million people in the UK alone. Through talks hosted by the Cambridge Rare Disease Society and events like RAREfest, we have gained insights into the challenges faced by the rare disease community. These include delayed or incorrect diagnoses, limited research and treatment options, and the significant social impacts on individuals and their families. As rare diseases are often overlooked, we are committed to raising awareness and supporting the community.

Rare diseases are closely aligned with Athena’s interests in paediatrics and genetics, as 75% of rare diseases affect children and 80% have a genetic origin. To explore this further, Athena took part in a patient-pairing scheme, where she learnt about FOP Friends and the challenges faced by young people living with a rare disease. A few months later, she came across a patient with FOP* — a reminder that raising awareness does make a difference!

*FOP = fibrodysplasia ossificans progressiva. This is an ultra-rare disease, affecting one in a million, where soft tissue (eg muscle, tendons, ligaments) slowly turn into bone. FOP Friends is the UK charity supporting people living with FOP and their families.

Why Cam Half for CamRARE?

We wanted to fundraise for rare diseases and CamRARE came to mind. Having attended RAREfest, we were inspired by the way CamRARE united patients, advocates, and experts to address the challenges faced by people affected by rare diseases. We believe meaningful change requires collaboration, and we appreciate CamRARE’s role in supporting the rare disease community. Additionally, a Cambridge-based charity seemed fitting for the Cambridge Half!

Two wishes for the future of rare disease and how you hope to help

Wish 1: That rare diseases are better understood and prioritised, reducing the stigma and isolation faced by affected families.

We can do our part in raising awareness, sharing stories, and advocating for policies that support rare disease communities.

Wish 2: That all patients, regardless of where they live, can access specialised care, affordable treatments and the support they need.

We hope that by fundraising for CamRARE, the charity can continue its incredible work in building supportive communities, and fostering collaborations with experts to improve treatments and coordination of care.

man in white runnign vest with back to screen. Text says runnign for rare on vest. a coloured toy bear looking over his right shoulder

Science, Meet Imagination: Rare Disease Research Reimagined Through Art Translations

Science, Meet Imagination: Rare Disease Research Reimagined Through Art Translations

The ART-TRAnslations Project, supported by Life Arc and the Cambridge Rare Disease Network, is more than just an art exhibition; it’s a radical merging of art and science designed to render rare diseases visible in new and imaginative ways. This visionary initiative pairs 20 scientists with 20 artists, resulting in a collection of awe-inspiring artworks that convey the science, struggles, and resilience of the rare disease community.

In one such collaboration, Dr Gavin McStay and ceramic artist Charlotte Morrison reinterpret mitochondria through ceramics, while Dr Katie Coveney and illustrator Lele Saa illuminate the realities of Noonan syndrome with an interactive activity book. These unique artistic expressions delve into the world of science through powerful, sensory storytelling, inviting audiences to connect with rare diseases in a profound and personal way. Here’s a glimpse into these remarkable collaborative journeys.

Cambridge Rare Disease Network - Science, Meet Imagination: Rare Disease Research Reimagined Through Art Translations 1

Exploring the Powerhouses of Life: Gavin McStay and Charlotte Morrison’s Mitochondrial Art

For Dr Gavin McStay, mitochondria are more than just cellular powerhouses—they are a fascinating microcosm of energy, life, and resilience. With a decade of experience in public engagement, Gavin’s passion lies in making science accessible through innovative, tangible means. Collaborating with ceramicist Charlotte Morrison, Gavin found a way to bring his research on mitochondria to life, inviting audiences to interact with intricate, hand-crafted ceramic pieces that embody the essence of mitochondrial structures.

Together, Gavin and Charlotte explored mitochondria’s role in life—from conception through to the final moments. They focused especially on mitochondrial diseases and the impact these elusive disorders have on patients through a humanistic perspective. This dialogue sparked an exploration that saw Charlotte translating the mitochondrion’s complexity and multifaceted role into ceramic forms, each piece capturing aspects of the cell’s strength, vulnerability, and essentiality to life.

“I want people to understand scientists and appreciate who we are and what we do,” Gavin expressed. There are profound similarities between scientific research and art: both demand observation, iteration, and creativity. I aim to make the world a better place by creating projects that engage and inspire, especially for young people who may one day become scientists.” Gavin’s enthusiasm for public engagement fuels his vision to make science not just educational but immersive and inspiring.

“I want people to understand scientists and appreciate who we are and what we do,” Gavin expressed. There are profound similarities between scientific research and art: both demand observation, iteration, and creativity. I aim to make the world a better place by creating projects that engage and inspire, especially for young people who may one day become scientists.”

Gavin Mcstay

Researcher

Charlotte’s ceramic works evoke the mitochondria’s delicate folds and ridges, symbolising both the resilience and fragility of these structures. Her approach allows visitors to not only observe the ceramic forms but also to hold and feel them, bridging a sensory connection to these vital cellular elements. Each piece bears quotes, associations, and fragmented text, woven together like a mosaic to convey the myriad roles mitochondria play in both health and disease. Charlotte dissected printed text and reconstructed it in strands, forming connections and organic shapes.

Their work is displayed on a pedestal, with each piece arranged to create a flowing path symbolising the ceaseless flux of metabolic activity. This sensory experience invites viewers to hold the pieces in their hands, feeling both the vitality and fragility of mitochondria, rendering science into something tangible and profoundly intimate. This collaboration has left Gavin feeling energised to take this concept further. At Liverpool John Moores University, he is already working with student artists in science and art master’s programmes to embark on new creative scientific projects.

Cambridge Rare Disease Network - Science, Meet Imagination: Rare Disease Research Reimagined Through Art Translations 2

Bridging Research and Compassion: Lele Saa’s Interactive Book on Noonan Syndrome

Cambridge Rare Disease Network - Science, Meet Imagination: Rare Disease Research Reimagined Through Art Translations 3

Lele Saa, an illustrator with a flair for character design, joined forces with Dr Katie Coveney to create a warm and engaging activity book tailored for children and families impacted by Noonan syndrome. Noonan Syndrome affects approximately 1 in 2,500 people worldwide yet resources that provide accessible and empathetic, non-clinical information can be hard to find. Inspired by Dr Coveney’s research on the lived experiences of those with Noonan syndrome, Lele brought to life a visually captivating, activity-rich book.

This interactive book includes word searches about the condition’s symptoms, an “I spy” game, a maze, and even a “chatterbox” featuring positive affirmations for caregivers. Lele’s illustrations invite children to learn and engage with the realities of Noonan syndrome in a playful, comforting way.

Cambridge Rare Disease Network - Science, Meet Imagination: Rare Disease Research Reimagined Through Art Translations 4
Cambridge Rare Disease Network - Science, Meet Imagination: Rare Disease Research Reimagined Through Art Translations 5

“I included care tips to caregivers like, ‘Do a silly dance’. It’s a gentle reminder for caregivers to prioritise self-care, shared in a way that a child could pass along to their parents. Katie and I worked closely to ensure these mindful activities were sensitive to the daily lives of caregivers.”

Lele Saa

Artist

Lele also designed a board game for families and the public to play together, highlighting the ups and downs of living with a rare disease. Initially, a “hospital appointment” card instructed players to lose 2 turns, but through thoughtful dialogue with Dr Coveney, the pair rethought this, reframing it as “you miss school for a hospital appointment, lose 2 turns” This subtle shift represents a powerful reframe, blending realism with optimism.

Reflecting on the project, Lele shared, “I learned so much, especially about the similarities people experience across different rare conditions. The most important takeaway is that, with the right support, people with rare diseases can truly thrive.” Her Noonan syndrome book will be displayed at Rarefest24 alongside her board game, providing visitors with a memorable, hands-on experience in learning about rare diseases. Lele’s upcoming children’s picture book and commissions showcase her commitment to intricate, impactful storytelling.

Celebrating Connections: The Artistic Process in Bridging Science and the Public

At the core of the Art Translations Project is dialogue—between scientists and artists, and between the artworks and the public. For instance, Gavin and Charlotte’s mitochondrial ceramics were showcased at the Lily Foundation Adult Support Weekend, where individuals affected by mitochondrial disorders had the opportunity to physically engage with the pieces. The response was both heartwarming and profound, as people expressed feeling an intimate connection to their health journeys and the strength required to manage their conditions. Likewise, Lele’s Noonan syndrome activity book is already making a difference, filling a knowledge gap and fostering a sense of community, fun, and understanding among families.

Rarefest24: An Unmissable Exhibition of Art and Science

This November, the full collection of 20 art-science collaborations from the Art Translations Project will be displayed at Rarefest24. Visitors will have the chance to witness this breathtaking array of artwork firsthand, each piece a testament to the transformative power of art in illuminating the complexities of rare diseases. Gavin and Charlotte’s mitochondrial ceramics will invite attendees to experience the sensory world of these cellular powerhouses, while Lele and Dr Coveney’s interactive Noonan syndrome book and board game will provide families with an innovative, playful way to learn about and connect with rare disease experiences.

Rarefest24 promises an unforgettable journey into the creative world of rare disease science, celebrating the resilience of the rare disease community and the imaginative power of art. Don’t miss your chance to experience this extraordinary fusion of art and science at Rarefest24, where the boundaries between imagination and discovery dissolve, leaving behind a legacy of inspiration.

The need for a rare patient passport

The need for a rare patient passport

Launching CamRARE’s ‘The Need for a RARE Patient Passport’ Report for Rare Disease Day

Today, we’ve joined our community in celebrating Rare Disease Day and sharing the progress that is being made to improve outcomes for people affected. Today seemed the perfect day therefore to launch our new report ‘The Need for a Rare Patient Passport’. Now the dust’s settled on a busy day let’s take a look at a simple way to make a difference for rare patients everywhere.

For those living with a rare or complex condition, it can be challenging to convey healthcare needs to relevant professionals, especially when an emergency arises.  To address this, some patient groups have devised “patient passports” and there are some excellent examples in use.

However, not every disease comes with a passport. In 2022 Rare-X reported there were as many as 10,867 rare diseases, affecting roughly 3.5 million people in the UK alone and @400 million worldwide, and designing a passport for each would be an impossible task. So our charity, Cambridge Rare Disease Network (CamRARE) has designed and trialed a patient passport that, in two phases of testing, was reported to be very helpful to both patients and healthcare professionals.

We are delighted to share our Phase Two Pilot study report which delves into the experiences of individuals with rare conditions in the UK, focusing on the challenges they face in communicating their healthcare needs and evaluating the potential benefits of a Patient Passport in enhancing communication between these individuals, healthcare professionals, and others in non-clinical settings.

The study involved over 200 patients and caregivers who participated in focus groups, completed pre- and post-pilot surveys, and tested a passport for up to 12 months. Additionally, healthcare professionals such as doctors, geneticists, nurses, and other allied healthcare professionals were engaged in sharing their experiences and insights. For the highlights of this report visit the Rare Patient Passport webpage.

Lucy McKay

The passport can be printed flat, single or double-sided for storage in a folder or to present to an HCP, or it can be kept folded in a protective wallet with a lanyard.

The findings from the report have enabled CamRARE to develop an updated version of the trial passport. This version is user-friendly, customisable, can be regularly updated, is downloadable, printable flat for storage in a folder, and foldable for easy carrying on a lanyard (see images and passport template attached). Whilst we are keen advocates of digital solutions, this current communication format was preferred by 74% of patients and offers an effective solution to a common challenge faced by many rare disease patients today.  The final version will be a fillable PDF format with guidance notes which can be used flat or folded.

We hope that this report can serve as a valuable resource for shaping policies and action plans within the Rare Disease Framework to improve co-ordination of care and education of healthcare professionals in rare diseases and that you will join us in encouraging recognition, adoption, and acceptance of the Rare Patient Passport as a means to alleviate the unnecessary challenges of communicating rare conditions for those affected, whatever their age and wherever they are. A tool which they can carry with them through childhood into adulthood.

 

Image depicts the small hand of a newborn held by the hand of an adult

Get involved

We would love your support and will be in touch regarding the launch of our new passport later in March.

  • Are you or a family member living with a rare condition? Register your interest in applying for the newly created passport (no surveys to fill out now this trial is closed).
  • Do you represent a patient community? Register your interest in adopting/adapting the passport for them.
  • Are you an HCP or involved in a healthcare, social care, or education setting? Register your interest in adopting/adapting or trialing the passport in your setting.
  • Are you a policymaker? Get in touch to discuss how we can collaborate to support people with rare conditions better.
  • Are you based outside of the UK or require passports in a different language? Let’s discusshow you could adapt the Rare Patient Passport.
  • Are you a company that’d like to support the development of this initiative? Let’s discuss how you could support our work.
  • Would your organisation or setting be interested in reviewing and providing an endorsement of this passport?  Get in touch

We hope you’ve had a successful Rare Disease Day 2024!

Many thanks for pro bono editorial, design and research support from

COSTELLO MEDICAL CONSULTING LIMITED Medidata Solutions and grant funding for this project from Alexion Pharmaceuticals, Inc.

 

Learning from the Rare Disease Community: Enhancing Facial Recognition AI Technologies for Improved Accuracy in Identifying Individuals with Facial Deformities

Learning from the Rare Disease Community: Enhancing Facial Recognition AI Technologies for Improved Accuracy in Identifying Individuals with Facial Deformities

Facial recognition technology has made significant advancements in recent years, transforming various industries and enabling efficient identification and authentication processes. However, one area where these technologies often fall short is accurately recognising individuals with facial deformities. This limitation has profound implications for people with facial deformities, who may experience challenges in accessing services, completing job applications, security checkpoints, and even social interactions. This blog explores how artificial intelligence (AI) could play a pivotal role in improving facial recognition technologies to accurately identify individuals with facial deformities.

 

Understanding the challenges

Facial deformities encompass a wide range of conditions, including craniofacial anomalies, burns, scars, birth defects, and other facial irregularities due to rare diseases. These conditions can significantly alter an individual’s facial features, making it difficult for conventional facial recognition systems to identify them accurately. Traditional algorithms are often trained on databases that primarily consist of images of individuals with typical facial appearances, resulting in biased models that struggle to recognise those with facial deformities. Amit Ghose, an Asian male born with Neurofibromatosis Type 1 (NF1) resulting in facial deformities, knows only too well the issues with AI and facial recognition:

“I feel that that AI is quite discriminatory. And someone who lacks confidence or someone who is insecure about their appearance already, to have that lack of facial recognition and rejection could be quite detrimental to their already lack of confidence that they have.”

Amit was determined to find out if AI could be improved to help in specific uses such as security at airports. His initial research highlighted that the solution seemed to be to bypass the system, and for those individuals not recognised, they would be escorted manually.  For Amit, this felt wrong.

“You can imagine if you’ve got a queue behind you, how humiliated you could feel if the system was still rejecting you. Now, how is that solution just to let people bypass a security feature?”

Amit Ghose

Motivational speaker, coach

The Role of AI in Improving Accuracy

Artificial intelligence offers promising solutions to address facial recognition technologies’ limitations when identifying individuals with facial deformities. By leveraging algorithms and advanced machine learning techniques, there is a very real opportunity to drive positive change for inclusivity. And that approach has to include partnership working with those communities that would benefit, as Amit suggests:

“The solution should be that you work with us to enhance the software and the application. You need to work with us to understand and raise awareness of the issues we face. So software companies, you guys need to do something.”

 

Amit suggests a call to action could include the following:

 

  • Diverse and Inclusive Training Data: To overcome the bias in training data, AI algorithms should be trained on more diverse datasets that include images of individuals with various facial deformities. Collecting and curating extensive databases with labeled images of individuals with facial anomalies can significantly improve the accuracy and reliability of facial recognition systems for this population.
  • Transfer Learning: Transfer learning enables the application of pre-trained models that have been trained on large-scale datasets, such as general facial recognition databases. These models can be fine-tuned using smaller, specialised datasets of individuals with facial deformities. By building upon the existing knowledge of facial features, transfer learning can improve the accuracy of recognition for individuals with facial anomalies.
  • 3D Facial Recognition: Conventional facial recognition systems primarily rely on 2D images, which may struggle to accurately capture and identify unique facial characteristics in individuals with deformities. 3D facial recognition, utilising depth-sensing cameras or other technologies, can capture the three-dimensional structure of a face, including subtle details. AI algorithms can then be trained to process this data and recognise individuals with greater accuracy, even in the presence of facial deformities.
  • Facial Landmark Detection: AI algorithms can be employed to detect facial landmarks, such as the position of the eyes, nose, and mouth, in individuals with facial deformities. By accurately identifying these key points, algorithms can normalise the facial images, compensating for deformities and making recognition more reliable.
  • Adaptive Algorithms: AI-powered facial recognition systems should employ adaptive algorithms that continuously learn and adapt to the unique facial features of individuals with deformities. This adaptive approach would allow the system to refine its recognition capabilities over time, enhancing accuracy and reducing false negatives.
  • Ethical Considerations: As with any AI application, there are important ethical considerations when it comes to facial recognition technologies for individuals with facial deformities. The utmost care must be taken to ensure privacy, data security, and protection against potential misuse or discrimination. Transparent data collection and model development processes, as well as ongoing audits, can help address these concerns and ensure that the technology is used in an ethical and responsible manner.

 

A future with AI

Facial recognition technologies hold immense potential to improve the lives of individuals with facial deformities by enabling accurate identification and access to various services. By harnessing the power of AI, through diverse training data, transfer learning, 3D recognition, facial landmark detection, and adaptive algorithms, we can overcome the limitations of current systems.

However, it is crucial to approach the development and deployment of these technologies with a deep commitment to inclusivity, fairness, and privacy. And to work closely with organisations, networks and individuals like Amit who experience and understand the challenges and wish to support AI technologies to develop and recognise them. With continued advancements and ethical considerations, AI can revolutionise facial recognition, providing a more equitable and accessible future for individuals with facial deformities.

“I think when it comes to educating everyone about how to deal with people with visible differences and also with rare diseases is where you can, as much as you can, try and treat them with that dignity, that they are normal and normalise everything.”

Amit Ghose

Motivational speaker, coach

We throw down the gauntlet to those working with AI to come and join us at RARESummit23. Amit will join us, alongside a wealth of diverse speakers, set to delve into the rare disease communities’ most pressing questions, scientific advances, and wishes for the future.

 

Embracing Resilience – The Journey of an Asian Male Living with Neurofibromatosis Type 1 and Facial Deformities

Embracing Resilience – The Journey of an Asian Male Living with Neurofibromatosis Type 1 and Facial Deformities

Life’s challenges come in many forms, and for some, the journey is exceptionally arduous. For Amit, an Asian male born with Neurofibromatosis Type 1 (NF1) and facial deformities, navigating childhood, adolescence, and adulthood was and is an emotional rollercoaster. This blog delves into the struggles and triumphs of a young man who has faced adversity with courage, resilience, and the determination to find acceptance and beauty in uniqueness.

 

As Amit states: “If there was better representation in the media, on social media, films (think of all the villains with facial deformities) and TV, I think that acceptance would be far greater than it is today. It’s going to take time for the people who have visible conditions and rare diseases to learn to accept who they are, embrace who they are, and celebrate who they are before we can expect others to accept us and others to give us time and appreciation. We need to do a bit of self-love, a bit of self-acceptance.”

“I hope we do get the acceptance and it’s not going to come overnight. It’s going to take time from both parties. It needs greater acceptance from society.”

Amit Ghose

Motivational speaker, coach

Living with Neurofibromatosis Type 1

Neurofibromatosis Type 1 is a genetic disorder that causes tumors to form on nerve tissue. While the severity of NF1 can vary significantly from person to person, facial deformities are not uncommon. As a child, Amit’s family began to notice these physical differences, which set him apart from his peers. He was just two years old when he was diagnosed and his father brought him to the UK in the hope of finding better treatment. Growing up, he faced challenges that most of us couldn’t fathom.

 

Childhood struggles

The early years were marked by innocent questions from classmates, curious stares, and insensitive remarks that left deep emotional scars. Finding acceptance in a world that often values appearance over substance was an uphill battle.

 

The bullying and social isolation

Throughout school, Amit endured bullying and ridicule, making him feel like an outsider. Social acceptance was a significant worry, and Amit dreaded going to school each day. The pain of being ostracised for something beyond his control was deeply distressing. He sought refuge in solitude, retreating from social interactions to avoid further hurt. The desire to fit in became a distant dream, and the search for authentic connections seemed almost impossible.

Going to school was challenging. The only friend I had was the support teacher because a lot of people didn’t want to be friends with me. She’s actually now a family friend. So whenever I meet her, we, we have these conversations, and you know, she told me the other day that there were many occasions we would just sit at lunch and I’d try and go out and, you know, I just couldn’t, I couldn’t integrate with other children. A lot of people were scared, a lot of people were worried they’d catch what I’d got. A lot of people didn’t want to be friends with me because they thought the cooler kids in the classroom wouldn’t want to be their friends if they were friends with me.

As the NF1 progressed, so did the physical differences, making everyday interactions even more challenging. At the age of 11, in year seven, I was told that my eye needed to be removed. You know, it’s a pretty daunting matter. And to digest that psychologically was a huge thing for me. Especially because I knew after I’d had the eye removed, I wouldn’t have the prosthesis for at least a year. So I’d be wearing an eye patch and going into school, wearing an eye patch, and that was daunting. Challenging, so that was a very difficult period when they removed the eye.

“I made a TikTok video, sharing my story, talking about my condition, talking about helping and inspiring people. And now 45 days after launch I have some 52,000 people following me. I never thought that would happen. But there’s a lot of people following and there’s a lot of schools now coming out to me and saying, can you come to our school? So it’s all about the education of school children, parents, friends, and society to reduce stigma and isolation. I think together we can make differences, positive differences, positive impacts, and my mission is to normalise visible differences.”

Amit Ghose

Motivational speaker, coach

Image depicts an asian gentleman with a beard and dark hair, and facial deformities particularly to the left side of his face. He is wearing a white jumper and blue blazer jacket.

Family support and coping mechanisms

Amidst the hardships, Amit found solace and strength in his family’s unwavering support and love. Their unconditional acceptance played a pivotal role in bolstering his resilience. Additionally, he discovered coping mechanisms like sports that allowed him to express himself freely and embrace his uniqueness. 

“I remember my dad was one of the biggest contributed factors of my confidence. The way my dad and my family brought me up, my dad never made me realise that I even have a condition. The way he dealt with me was completely as if I was just one of the other siblings. And that really helped the mentality of normalizing things for me.”

 

Overcoming obstacles

As he entered adolescence, Amit chose to confront the challenges head-on. He sought other ways to address the emotional toll of living with facial deformities, which proved instrumental in boosting his self-esteem. Slowly, he began to build a sense of self-worth, recognising that his value extended far beyond physical appearance. “The turning point, I think, was when I started accepting who I was, and I started, you know, realising unconsciously that, you know, I can’t really change who I am, and I can’t change the way I look, and the condition I have, but what I can do is try and be who I am.

So, I started playing cricket. I joined the cricket club, and suddenly, I went from the guy who has this rare disease guy who plays cricket. It’s that shift in people’s mentality and people’s perceptions about people who have diseases that you are not the disease. I’m not only recognised as Amit, the guy with the neurofibromosis, or Amit, the guy with NF, that one. I’d rather be recognised as Amit, the guy who plays cricket, or now Amit, the guy who’s going on trying to raise awareness and trying to help support, inspire people around the world about this subject.”

Amit’s condition is hereditary, and he has a fifty percent chance of passing it on. This brought further challenges from the Asian community. “So when I was at the age of getting married, a lot of people in in the community were saying, who would give their daughter to him? Somebody even came up to me and said, oh, put yourself in the shoes of a father. Do you want your daughter to marry someone who’s got a condition like yours? It’s unbelievable that someone can say that to you straight to your face. Then I met my wife, and when we moved into the dating phase, her family was completely against us getting married. One of the biggest reasons for that was how will the children turn out?

So now Amit and his wife are on a new journey, working with the genetic consultants to see if they can mitigate the genetic risks of passing down the faulty genes and how or if they can be removed in pregnancy. This in itself has opened up questions for Amit and his wife. Amit, in particular.

“Ultimately, it came down to do I want my child to go through what I’ve been through? And the answer is no. But as with all things in my life, it puts a huge mental strain on me, but we are now in this phase where we’re considering our options, we’re talking to specialists, and seeing what could be done.”

 

Image shows a young asian male with facial deformities in blue jeans and a graphic tee standing in his childhood home.

Advocacy and Empowerment

As an adult, Amit transformed his struggles into a platform for advocacy and empowerment. He has now become an active voice within the NF1 community, educating others about the condition and promoting awareness about facial differences. By sharing his story, he aims to inspire those facing similar challenges and eradicate misconceptions surrounding facial deformities. Reflecting back on his school days, Amit believes that:

“You know, I felt like I had two choices in life. I could either sit back and feel sorry for myself or I could get up and be who I am. So the journey from when I had the eye removed, the eye patch, the name calling, the bullying, you know, going into school, being called Captain Hook, Popeye, the sailor man. All these names that still come back to and haunt me sometimes was really depressing and really, really upsetting. I tried to use my personality. I try to say to myself, accept who you are. Embrace who you are, celebrate who you are, and go out and be yourself.”

Rather than succumbing to the societal pressure to conform, Amit has chosen to redefine facial deformity on his own terms. He challenges conventional beauty standards, emphasising that true beauty lies in accepting and embracing individuality and diversity. Through his advocacy work, he hopes to foster a more inclusive society that celebrates differences rather than stigmatising them.

Embracing individuality

The journey of an Asian male growing up and living with Neurofibromatosis Type 1 and facial deformities is a testament to the indomitable human spirit. While the path was fraught with challenges, Amit’s resilience and determination allows him to rise above adversity. By embracing his uniqueness and advocating for awareness, he has become an inspiration to many, proving that true beauty emanates from within. Through his story, we learn that by accepting and celebrating our differences, we can foster a world that embraces and uplifts every individual, regardless of their appearance.

 Come and meet Amit at RAREsummitt23!

CamRARE endorses the importance of understanding the diagnostic odyssey for Rare Disease Day

CamRARE endorses the importance of understanding the diagnostic odyssey for Rare Disease Day

Understanding the challenges facing families seeking diagnosis for a rare condition, often called the diagnostic odyssey, is crucial, says CamRARE, the Cambridge Rare Disease Network.  A diagnostic odyssey is described as the time is taken between when a symptom or feature of a genetic or rare disease is observed to the final diagnosis.

The waiting game

The average waiting time for a final diagnosis is currently estimated to be around five years and can involve the input of, on average, 4-5 doctors. But it can often take much longer, or result in being unable to diagnose. For many families, navigating their child’s diagnostic odyssey can be a long and painful journey. Trying to find answers to why their child presents with specific characteristics and health conditions and trying to understand what is causing them can be difficult, time-consuming, and a trying process that takes its toll. Danielle and her husband know all about this. It took them over four years to obtain a diagnosis for their son Reuben and they met many different consultants along the way. As Danielle explains:

“Reuben had his first testing at less than 6 months old – neither of these gave us or the doctors any answers. At this point, Reuben was referred to Great Ormond Street Hospital. We first met in July 2019, when Reuben had just turned one. In February 2020 Reuben had bloods taken for Whole Exome Sequencing (WES) This returned a normal result. There are many challenges that come with having a child with an undiagnosed condition. There is guilt, isolation, frustration, and stress, amongst many other emotions. From very early on in Reuben’s life we began to feel isolated and alone, that we didn’t ‘fit in’. Without a diagnosis it was very difficult to answer questions about Reuben.

Not being able to find the answers is a frustrating process for families. Numerous clinic visits, hospital stays, and tests that still seem to provide no definite answer make the diagnostic odyssey a traumatic one for many families as they attempt to manage a child’s symptoms without knowing their cause and the best way to support them.

The burden of care

We had an appointment with the geneticist every 6 months, so that she could be updated on Reuben’s development, and find out whether any new medical complications had arisen that may give her more clues. Reuben’s geneticist was very clear from the start that we may not find the answer to Reuben’s difficulties for a number of years, and potentially never.

Danielle D Sansum

New technology, new hope

For those who have experienced a diagnostic odyssey like Danielle, advances in genomics – and especially whole genome sequencing offer hope. Whole genome sequencing, WGS, is a laboratory technique in which the entire coding and non-coding regions of the genome are obtained. It provides a comprehensive map of a person’s genetic makeup and allows extensive analysis of all genes. The hope is that the speed of genomic technology advances will continue to increase and provide families with an answer. Danielle was delighted to finally get a diagnosis for Reuben.

For those who have experienced a diagnostic odyssey like Danielle, advances in genomics – and especially whole genome sequencing offer hope. Whole genome sequencing, WGS, is a laboratory technique in which the entire coding and non-coding regions of the genome are obtained. It provides a comprehensive map of a person’s genetic makeup and allows extensive analysis of all genes. The hope is that the speed of genomic technology advances will continue to increase and provide families with an answer. Danielle was delighted to finally get a diagnosis for Reuben.

In May 2021, when genetic testing was becoming more readily available on the NHS, Reuben was deemed suitable for Whole Genome Sequencing, to be carried out at East Genomics in Cambridge. This was the test that gave us the diagnosis.

Danielle D Sansum

What’s in a name?

For the family it meant that they had a name- the condition is called OTUD5-related neurodevelopmental disorder. They learned it is a relatively recently discovered disorder, and there are less than 50 known cases worldwide. Reuben is the only person currently diagnosed in the UK. It also meant that they could understand Reuben and the difficulties he will face as the diagnosis provided them with a list of commonly associated complications. For Danielle, it also helped her look to the future.  

She explained ” We want Reuben to be happy in life, for the good days to outweigh the bad, and more than anything we want him to learn how to effectively communicate with others, in whatever form that might be. We know that Reuben’s condition is lifelong, but we now know how to explain Reuben’s presentation to others, and it should mean we can easier access care and support services when needed in the future. “

How CamRARE can help

CamRARE wants to support more families such as Danielle’s and have a lively and growing community for families living with rare and undiagnosed conditions called Unique Feet. Jo Balfour, Managing Director,  explains why giving families the space to come together is important

Danielle echoes this:

” What is so fantastic about Unique Feet is that it gives children and young adults opportunities that they may not necessarily experience otherwise, and for us as parents, it allows us the space to feel completely relaxed – there are no looks from others when Reuben falls to the floor when he becomes overwhelmed – everyone is in the same boat, everyone understands. which is why it’s so important that these types of support groups exist.”

Cambridge Rare Disease Network - CamRARE endorses the importance of understanding the diagnostic odyssey for Rare Disease Day 6

Challenges facing families after a rare disease diagnosis

Challenges facing families after a rare disease diagnosis

Cambridge Rare Disease Network talks to Karen Whitehead about the challenges of parenting, living and working with a rare disease diagnosis within the family.

Kate Whitehead was 28 when she was told that she had Pregnancy Associated Osteoporosis which is a very rare form of osteoporosis, sometimes leading to extreme bone mass loss. In most women, osteoporosis will partially or fully recover spontaneously after the pregnancy. For Kate, it meant decades of living with an invisible disability.
Osteoporosis literally means ‘porous bones’ and can be a severely disabling disease. Each year it causes hundreds of thousands of hip and other fractures in the UK alone. For Kate, it meant also that she had additional worries about being able to be a good parent or if she could consider any future pregnancies. Even more worrying was what would it mean for Kate’s daughter. Kate explains

“What is also unknown, is the impact on our children, of this bone disease. Addenbrooke’s hospital also took on my daughter as a patient, when a dexa scan showed she had osteopenia in her 20s”.

Cambridge Rare Disease Network - Challenges facing families after a rare disease diagnosis 7

Kate was very fortunate in being referred to the Addenbrooke Hospital under the Metabolic Bone Disease Unit where she remains a patient to this day. As advances in genetic testing become more available this can provide much-needed support to families. Kate was delighted to be able to take advantage of more available testing and treatments.

“Addenbrookes enrolled us both in their GEL genetic research and also the UK’s 100,000 genome research project. However, although I was incredibly worried when she fractured after a fall recently, all our family were delighted to hear that her latest dexa showed she had normal bone density for her age. The impact on our children of this rare disease remains unknown, but where most cannot obtain dexa scans, my daughter’s latest medical information has truly given hope to so many other PAO mums & their children”.

 For me, the wheel has now come full circle, my daughter is newly married and I am looking forward to becoming a grandmother. Now, thanks to Addenbrooke’s hospital care, I will be able to pick up and cuddle my grandchildren and play with them – to do things with my grandchildren I was unable to with my own child.
Karen Whitehead

Rare disease patient

Whilst Kate and her husband have moved to be nearer to their daughter, she has maintained long-distance Addenbrooke’s hospital support which is still very important for her and her family.

Sadly, Pregnancy Associated Osteoporosis continues to remain a rare, unknown disease. However, there is now progress being made to better understand this debilitating condition and offer hope to new mums. For the first time in 30 years, there are two major new UK research projects, the Royal Osteoporosis Society funded project at the University of Edinburgh and also the Royal National Orthopaedic Hospital in-house funded project. Furthermore, PAO is also now included in the Rare Undiagnosed Disease Study study of rare bone diseases, by the University of Oxford. These research projects will set the future for better detection, prevention and care. Kate fully recognises this importance.

“I believe that Addenbrooke’s hospital Rare Bone Disease Clinic has one of the largest clinical groups in the UK of patients with pregnancy-associated osteoporosis and they are fully supporting the new research and helping their patient participation, by arranging blood tests and providing patient data to the research teams. I recently met up with some of the young mothers with this disease, when I was last in Cambridge for my annual clinical consultation. It was so upsetting to learn these young mothers are still facing a terrible diagnostic odyssey, over 30 years since I was diagnosed with such difficulty. This particular rare disease truly needs to be diagnosed quickly, to prevent further harm to both mothers and their babies.”

Addenbrooke’s is also supporting the Pregnancy Associated Osteoporosis group of patients and Cambridge Rare Disease Network, in currently trying to raise awareness about this condition. At present, there is a new campaign being held around Rare Disease Day 2023.

 

Living with a very rare bone condition

Living with a very rare bone condition

Pregnancy is normally a time of excitement for mums to be. But for some, it is a catastrophic event due to a rare condition called pregnancy-associated osteoporosis (PAO). As Karen Whitehead, herself felt.

‘27 years ago, I was about to have my first baby. My husband and I were excitedly anticipating our new family life. Instead, I experienced back pain during the last few weeks of pregnancy and my spine collapsed in labour, leaving my back broken in four places and me three inches shorter. However, nobody in the hospital would believe anything serious was wrong and I was discharged home 24 hours after giving birth’

When we think of osteoporosis, we often associate the condition with older members of our society, rarely expecting pregnant women to be affected. PAO is a severe type of osteoporosis that arises during pregnancy, after delivery, or during breastfeeding. Women lose some calcium from their bones during a normal, healthy pregnancy and breastfeeding. But in women with PAO, that calcium loss leads to significant bone fragility, particularly in the vertebrae. They can have spine or other fractures with little or no trauma. It is so rare that clinicians currently understand so little about PAO. Indeed, research on what could cause bone fractures during pregnancy is still very much in its infancy, with many cases going undiagnosed or prompting further investigation due to the condition’s rarity.

Clinicians do not know how many women have it and for many obstetricians they will never have encountered women with it, making for a challenging diagnostic pathway when a woman presents with PAO.

In the most common scenario, PAO is discovered after a pregnant or breastfeeding woman complains of severe back pain, and imaging reveals multiple vertebral fractures. Most of these women would not have had a bone assessment before this happens, and there is often a considerable delay between the onset of symptoms and diagnosis.

Karen is one of these women who aged 28 had a spinal collapse whilst in labour. She found herself in a situation where not only could she not look after her baby but struggled to be believed and like others with this condition Karen explains her frustrations.

Cambridge Rare Disease Network - Living with a very rare bone condition 8

“A terrible diagnostic odyssey, with hospital staff, midwives, health visitors and my GP refusing to believe my husband and myself that anything was wrong. My husband insisted we had to change GP and thankfully our new GP listened, believed us and started testing. But they had never heard of Pregnancy Associated Osteoporosis (PAO) and so were not testing or looking for it. Eventually, though an x-ray revealed spinal fractures, my back broken in different places, from labour and trying to lift my baby. Even seeing the x-ray, my GP queried had I ever been in a car crash or had any back injury previously.”

Women with PAO and vertebral fractures may have excruciating back pain, which can make it difficult to function and even more difficult to care for a baby. Women may also have other types of fractures that require urgent care. Aged 28, Karen was told that she had the bones of a 99-year-old woman and she was not allowed to hold, lift or carry her baby, for medical fear of new fractures.

 “‘Parenting with a new, disabling, painful, rare condition was incredibly difficult over the years. This particular bone disease has a huge mental health impact, from birth trauma to the feeling of failure as a mother, the impact on career, finances, and relationships, the horrific change in body shape arising from vertebral fractures and the ongoing fear of fracturing and living with huge amounts of pain’

Karen Whitehead

Rare disease patient

Karen found herself living a restricted life and had a long period as a wheelchair user, her family living constantly in the shadow of this frightening and debilitating disease. There is no mutually agreed opinion or guideline in the treatment of this condition and Karen found herself moving around hospitals and specialists, still without a treatment plan that would work for her. At the age of 50 she was still struggling physically and mentally.

“After 20 long years of this, I was approaching 50 and the menopause – the age when women usually get osteoporosis and break bones. In that immediate post-menopause period, women can lose up to 20% of bone and one in two women aged over 50 have osteoporosis and fracture. I’d already lived with severe pregnancy-associated osteoporosis for twenty years. I was already having ongoing easy fragility fractures. I was terrified of the future and the menopause”.

Luckily for Karen help was at hand, in the shape of Dr Ken Poole. Dr Ken Poole is a University Lecturer and honorary consultant rheumatologist at the University of Cambridge, who applies novel imaging techniques to investigate human bone diseases. Research in his bone group focuses on osteoporotic fragility fractures and osteoarthritis by examining the bone structure and shape in health and disease. Karen became and continues to be a patient at Addenbrooke’s Hospital under the Metabolic Bone Disease Unit, Dr Poole was able to direct Karen towards a new bone treatment and for the last ten years, this team has supported Karen through the menopause and beyond. Prescribing and advising on various ongoing bone treatments, some of which they have been instrumental in developing. Karen is delighted to be in a much better position and is excited that,

“From having the bones of a 99-year-old age 28, I am now 60 and my bones are now those of a 60-year-old. I have not had a single fracture, since being taken on by Addenbrooke’s amazing Hospital as a long distant patient”

Cambridge Rare Disease Network - Living with a very rare bone condition 9

Destroy mutant mitochondrial DNA with MRC-MBU at RAREfest22

Destroy mutant mitochondrial DNA with MRC-MBU at RAREfest22

The strategic mission of the MBU is to understand mitochondrial biology in health and disease, and to exploit this understanding to develop new therapies and improve human health.

Alex Whitworth is a Group Leader at the Medical Research Council Mitochondrial Biology Unit (MRC-MBU) and leads one of the 9 teams within it. Penny Peck is the Communications and Postgraduate Manager, supporting the postgraduate students and coordinating the programme of public engagement activities.

Financed largely by the Medical Research Council, Alex and his researchers focus on understanding the fundamental biology of mitochondria, a particular part of the cell, that sometimes go wrong and cause disease. As he explained:

“The emphasis of our research is mitochondria. Mitochondria are a particular part of the cell found in almost every cell of the body and best known for being the powerhouses of the cell – the cellular batteries. They are a real hub for metabolic processes that convert the food that we eat into actual useable energy within our bodies. So, directly or indirectly, they influence virtually every single process that goes on within our bodies. Because of this, problems with mitochondria often affect our most active tissues, such as the brain, our muscles and heart.”
Alex Whitworth

Group Leader

The unit’s role encompasses understanding many of the basic functions of mitochondria, and in particular investigating how this contributes to or directly causes a range of diseases. Therefore, the researchers are working on areas such as heart disease and stroke. Alex’s research is focussed on neurodegenerative diseases and typically the more common neurodegenerative diseases, such as Alzheimer’s and Parkinson’s.

A very special feature of mitochondria is that they have their own small genome,(DNA) which is susceptible to mutation. So, there are some very specific types of diseases which are caused by the mutation of the mitochondrial genome. While these tend to be relatively rare types of diseases, natural variations in the mitochondrial genome also influence a wide range of more common conditions.

Another interesting phenomenon of the mitochondrial genome is that it is transmitted exclusively through the maternal line, so you inherit all your mitochondria DNA from your mother. As opposed to half the copies of the nuclear DNA coming from mum and half from dad. This establishes an interesting clinical solution for mitochondrial diseases that show an unusual inheritance pattern. As Alex explains:

“Advances that have happened in the last few years are aimed at tackling some of these mitochondrial diseases, including one solution coined the ‘3-person baby’. As you have genetic contributions from mum and dad, for the majority of the genome, and mum only for the mitochondria genome, if there is a problem only with the mitochondria genome but the rest of the genome is perfectly fine, you could simply replace the mitochondrial genome with a good set. For example, using in vitro fertilisation, you can replace the mitochondria that are bad with mitochondria which are good from another maternal donor. This then means mum, dad and a third person contribute to the baby. Hence the name ’3-person baby’. In theory this should be able to cure a lot of these diseases. And excitingly the UK is one of the leading centres in the world that is pioneering this technology. ”

Alex and Penny are excited to bring a special game to RAREfest22 which enables them to talk about the research described above and allow people to better understand how mitochondria have their own genome, and explain how one of the therapeutic angles is to try and remove the bad mitochondria and the kinds of technology the research teams in their unit have been developing. As Penny explains:

At RAREfest we will have a number of specialist biology researchers on hand to help with our game and explain the science! We will have mitochondria looking like how they appear in our cells, along with ‘good’ mitochondrial DNA (green balls) mixed with ‘bad’ mitochondrial DNA (black balls), and the challenge will be to place all the bad in our mitochondrial DNA dustbin!

Both Alex and Penny wish to showcase that this is an exciting time for mitochondrial research and translational science. They both firmly believe that researchers are on the cusp of now being truly able to translate the research and technological developments into viable therapeutic approaches. And whilst there is still some way to go regarding safety and efficacy, it is about hope and knowing that they can make a real difference in the delivery of solutions in the foreseeable future.

So come and see Alex, Penny and their team at RAREFest22 – learn and have fun on the day!

Rare Youth Revolution at RAREfest22

Rare Youth Revolution at RAREfest22

Chelsea Wong is the Youth Coordinator for Rare Youth Revolution (RYR). Rare Youth Revolution is a global news and opinion, digital magazine platform, dedicated to powering up the voices of the young people in the rare disease community. They aim to bring quality news, for young people, by young people.

They are part of, but different to, their main magazine, Rare Revolution which focusses on adults living with a rare condition. Rare Youth Revolution instead, focusses on young people living with a rare disease as that is an entirely different audience. Their aim is to amplify their voices and give them a safe space to feel heard. As Chelsea explains:

We want young people to feel supported and safe in telling their story and to know they are being heard and listened to. Rare Youth Revolution is about empowerment and inspiring open and authentic stories told by young people for young people.

Chelsea, in her role as Youth Coordinator and also living with a rare condition herself is well-placed to coordinate and support the wide range of opportunities for these young people. She can help them raise awareness about their specific condition in a range of formats from writing to video, art, and social media campaigns. Chelsea is delighted that one of their initiatives called Rare Talks provides an opportunity for people living with the same rare disease to discuss, through video, the surrounding issues of living with the same condition. It also gives them the chance to share similarities and differences of their lives, despite living with the same rare disease.

“I was trying to find that perfect balance for me, being able to express myself in a work environment, and work well whilst living with my condition. So, this seemed like the perfect fit, so I just went for it and here I am!”
Chelsea Wong

Youth co-ordinator

Exhibiting at RAREfest22

One of Chelsea’s first tasks was to sort out their presence at RAREfest22. She will be contributing in two ways. The first is a session called Rare Monologues, where the RYR team will work in collaboration with Medics4Rare Diseases. Four people from the RYR team will perform a short monologue speaking about difficult conversations. This includes medical gaslighting, trying to put your foot through the door, advocating for yourself in medical appointments and trying to be heard. All topics can be difficult to speak aloud and be incredibly overwhelming, especially for young people. This impactful session invites these young advocates to speak to the room and feel listened to.

RARE youth Revolution Experience

Secondly, Chelsea is bringing an interactive session as an exhibitor. Her stand will showcase the human body with numbers on it. Behind each number will be an audio of symptoms relating to that specific area. Plus, it provides further information of a lived experience by a young person about their actual condition rather than just the symptom itself. Chelsea explained the rationale:

I have tried really hard not just to make it educational, but also interactive and easy to follow. I also wanted to make sure it was very personal. When people listen to these audios, they will be listening to an actual person who is talking about their condition. I want the public to see the variety of rare conditions, but also how young people differ and go about their lives in a different way once they have adapted to those symptoms, since they have been diagnosed.

Come and see Chelsea and her Youth Team at RAREfest22 and see for yourself the issues that matter to young people living with a rare disease and how young people live positively with their condition!

Finding a needle in a haystack

Dr Kate Downes is the Clinical Scientist Lead for the East Genomic Laboratory Hub. Genomic medicine is a rapidly growing and dynamic field, and we are increasingly finding
more answers to help us provide more results to patients and their families.

The East Genomic Laboratory Hub (GLH) provides genetic testing for patients in the East Midland and East Anglia regions for both rare disease and cancer as part of the NHS Genomic Medicine Service. As the Rare Disease Clinical Scientist Lead, Kate works across the three genetic laboratories within the region at Cambridge, Leicester and Nottingham. All three laboratories receive rare disease test orders from doctors and healthcare professionals for patients who have a suspected genetic disorder. Genetic testing may be performed in house, with technologists generating genetic data, bioinformatics teams analysing results and Clinical Scientist interpreting the genetic variants identified and generating clinical results reports. As Kate explains, for some specialist genetic tests, the East GLH sends DNA to one of the other six GLHs in England to perform genetic testing and the East GLH also receives DNA for testing for specialist testing performed at the Cambridge Genomics Laboratory. In this way, the seven GLHs work in partnership to offer comprehensive genomic testing for all NHS patients.

This is a thrilling time to be working in the world of genomics, as explained by Kate.

“We are using new technologies and we are introducing new technologies all the time to perform testing in patient samples to identify the cause of their rare disease and clinical symptoms. We are translating new techniques, tests and analysis methods alongside using the latest understanding of new genes and disorders. We can now use big databases of genetic data from population and patient cohorts generated across the world. These resources help the Clinical Scientists interpret a new genetic variant we have identified in a patient. The questions we ask is: has this genetic variant been seen before in another patient with similar clinical symptoms? If the answer is yes then it is likely that this genetic variant is the cause of the patient’s disorder.”

“Together the introduction of new technologies and analysis methods with increased data sharing across the world help is provide more and more genetic diagnosis to patients.”
Dr Kate Downes

Clinical Scientist Lead

Having been an academic scientist for most of her career, Kate decided to move into the NHS. Supported by colleagues at the University of Cambridge and the NHS Cambridge Genomics laboratory, she was trained and gained experience that enabled her to register as a Clinical Scientist. She has worked in the Cambridge Genomics Laboratory as a Clinical Scientist for three years now and has welcomed the opportunity to take on her current role as the East GLH Clinical Scientist lead.

Kate loves her job, working with a huge team of people who are enthusiastic and incredibly knowledgeable in lots of different areas, located across the East region.

 

Dr Kate Downes
Genomics Lab CUH Hospital

My day to day role is really varied. I get to speak with members of the East GLH team within the Cambridge, Nottingham and Leicester laboratories, I also take part in national discussions to improve and standardise genomic services and improve patient pathways. And why do I love doing that? The reason I am in this role is to provide the best possible service for patients and their families right now, but also importantly to bring in new technologies, processes and knowledge into the laboratory to improve testing strategies in the future.

Come and join Kate and the East GLH team at RAREfest22, as they help people understand the genetics of rare disease. Do you fancy a career in health science?

We would really like to inspire young people to consider a career in healthcare science within the NHS. So at RAREfest22 we will have some fun activities alongside the opportunity to ask questions for our Clinical Scientists, Genetic Technologists and Bioinformaticians. We are planning to entertain and hopefully educate and inspire the next generation of healthcare
scientists!

Report Launch Feb 2022: Improving transitions to adult care for young people living with a rare disease

Report Launch Feb 2022: Improving transitions to adult care for young people living with a rare disease

Costello Medical, Cambridge Rare Disease Network and Beacon launched a new report in March 2022 exploring the transitions process for young people living with rare conditions.

In recent years, advances in the diagnosis and treatment of rare diseases have led to improved life expectancy and quality of life for many patients. Consequently, children with complex and chronic rare diseases, who previously may not have survived past infancy, are now expected to live well into adulthood. The increasing number of patients transitioning from paediatric to adult care has placed growing pressure on healthcare systems to develop age-appropriate services that ensure continuity of quality care.

Characterising Key Challenges 

While improving transition pathways is an area of increasing focus, the rare diseases community continues to face substantial challenges when it comes to transitioning from paediatric to adult services. As such, there is a need to identify and characterise key challenges, as well as potential solutions, in order to inform further policy change and improve the transition processes for patients with rare diseases.

In response to this need, Costello Medical in collaboration with Cambridge Rare Disease Network [CamRARE] and Beacon held a series of focus groups throughout 2021 and a round table discussion on 15th October 2021 comprising of healthcare professionals, patients and caregivers, patient advocates and policy experts.  This diverse group shared their insights and experiences of transition services at different hospitals in Cambridgeshire and surrounding regions. The report, titled ‘Improving transition from paediatric to adult care for young people living with a rare disease’ recently published, discusses the current challenges associated with the transition of young adults with rare diseases into adult healthcare services, we well as identifying potential solutions and clear recommendations for action.

In the UK Rare Diseases Framework published Jan ‘21, it is recognised that we must address “the challenges in ensuring continuity of care across paediatric and adult services” to reduce the burden of care on patients and their families.  Transition has been described as “the purposeful and planned movement of adolescents and young adults with chronic physical and medical conditions from child-centred to adult orientated healthcare systems”. But were their experiences planned & purposeful? Within the report, young people living with #RareDiseases share their lived experiences and tell us what was done well, what could be done differently and how the process could be better.

Some of the key challenges outlined were the definition of transition, a lack of coordinated care, insufficient transparency and communication, the timing of transition, changing roles of parents, limited consideration for wellbeing, a fear of moving to adult care, and lack of age-appropriate care.

“Despite attempts to initiate conversations about transition as a teenager, my transfer into adult care came about abruptly, when I was admitted to the A&E department as a young adult. This was shortly after my primary paediatric doctor retired.” Katie also admitted, “I still don’t know who I’m really supposed to go to for what issue.”

Katie Callaghan

Founder , Cards for Bravery & young adult living with a rare condition

Rare-Diseases-Paediatric-to-Adult-Care-Transition_Roundtable-Report_1

Solving the Problem

What was most exciting and filled us with hope for a better future was the solution focussed discussion which took place next.   We heard of great practice in action at Colchester NHS where they adopt the #ReadySteadyGo transitions programme and have a Youth Worker who supports holistically, helping young people share experiences and plan ahead in an age appropriate, engaging way.

“Encouraging young people to share their experiences with their doctors can be powerful, and have a bigger impact.”

Rachel Fletcher

Hospital Youth Worker, Colchester Hospital

We were also impressed by the Teenage and Young Adult (TYA) ward at Addenbrooke’s Cambridge University Hospital which offers space for patients aged 14 to 24 for treatment of cancer. Young people helped with its design to create a less daunting stepping-stone in transition from paediatric to adult wards. The ward provides a focal point for young adult care, bringing together a multidisciplinary team (MDT) of clinicians, youth workers, social workers and mental health support workers. This MDT structure is important in determining the right time to initiate transition for each individual, based on factors such as developmental age and family structures. Everyone who works in the ward engages with the young adults and communicates with them about their future aspirations and goals, rather than just their illness. This environment has been invaluable in providing patients and their families with the necessary support throughout the transition from paediatric to adult care.

Based on the solutions discussed as part of the focus groups, a set of four key recommendations were compiled and it is hoped that they will help to improve the transition from paediatric to adult care for young people living with rare diseases in the Cambridgeshire region and beyond.

You can find the full report here. Please take time to read, digest and share so that together we can get transitions right for young people living with rare conditions.

transition to adult care summary of recommendations